infectious disease – F.I.G.H.T for your health! http://lymebook.com/fight Linda Heming describes her Lyme disease healing journey Wed, 06 Nov 2013 05:54:37 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.25 Facial Lyme Symptoms http://lymebook.com/fight/facial-lyme-symptoms/ http://lymebook.com/fight/facial-lyme-symptoms/#respond Fri, 14 Jan 2011 17:52:59 +0000 http://lymebook.com/fight/?p=2035 Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21186776&retmode=ref&cmd=prlinks

Excerpt:

Lyme disease (borreliosis) is an infectious disease caused by the Borrelia
spirochaetes, usually transmitted to humans by the Ixodes ticks. It is
manifested by a wide spectrum of clinical symptoms varying according to the
time elapsed from the infection. The paper describes orofacial symptoms of
the disease in a woman who has suffered from a chronic borreliosis for 3
years.
Multiorgan clinical manifestations of borreliosis might occur in the
masticatory organ and this fact should be taken into consideration in the
differential diagnosis of pain by medical and dental practitioners.

]]>
http://lymebook.com/fight/facial-lyme-symptoms/feed/ 0
Martin Pall talks on Chronic Disease (with comments from Dr. Gordon) http://lymebook.com/fight/martin-pall-talks-on-chronic-disease-with-comments-from-dr-gordon/ http://lymebook.com/fight/martin-pall-talks-on-chronic-disease-with-comments-from-dr-gordon/#respond Wed, 22 Dec 2010 05:57:29 +0000 http://lymebook.com/fight/?p=1983 Martin Pall has made a major contribution to our understanding of many of the CHRONIC degenerative diseases we see today. I like the fact that this provides a molecular based explanation that leads to improved understanding of the need for a total nutritional support program in these diseases, which our colleagues all too often dismiss as psychosomatic.

This link will take you into well written materials by Dr Pall that may add to your ability to move beyond today’s differential diagnosis into a more comprehensive understanding of what is really going wrong when our patients develop fibromyalgia, chronic fatigue, chemical sensitivities, etc.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.thetenthparadigm.org/

Excerpt:

Novel Disease Paradigm Produces Explanations for a Whole Group of Illnesses

A Common Causal (Etiologic) Mechanism for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, Multiple Chemical Sensitivity, Fibromyalgia and Post-Traumatic Stress Disorder

Martin L. Pall, Professor Emeritus of Biochemistry and Basic Medical Sciences,
Washington State University and Research Director, The Tenth Paradigm Research Group.

The Tenth Paradigm of Human Disease

The basic proposal that is developed here and is amplified further in my book and in my other web pages, is that the NO/ONOO- cycle explanatory model is the tenth major paradigm of human disease.  There are nine well-accepted paradigms listed below along with the NO/ONOO- cycle:

Major Disease Paradigms

1.   Infectious diseases.

2.   Genetic diseases.

3.   Nutritional deficiency diseases.

4.   Hormone dysfunction diseases.

5.   Allergies.

6.   Autoimmune diseases.

7.   Somatic mutation/selection (cancer).

8.   Ischemic cardiovascular diseases.

9.   Amyloid (including prion) diseases.

10.  NO/ONOO- cycle diseases

]]>
http://lymebook.com/fight/martin-pall-talks-on-chronic-disease-with-comments-from-dr-gordon/feed/ 0
Humoral Immune Response in Dogs with Borrelia http://lymebook.com/fight/humoral-immune-response-in-dogs-with-borrelia/ http://lymebook.com/fight/humoral-immune-response-in-dogs-with-borrelia/#respond Wed, 14 Jul 2010 05:57:33 +0000 http://lymebook.com/fight/humoral-immune-response-in-dogs-with-borrelia/ Excerpt:

Lyme arthritis in dogs can be induced under experimental and
natural conditions.
However, the veterinary relevance of canine borreliosis is still
under extensive investigation. The prevalence of symptoms is
clearly low although the risk of tick exposure is high. Current
research focuses on case definitions, methods for diagnosing
clinical disease in dogs, and discrimination between an immune
response to a natural infection versus vaccination.
In this experimental study,
23 dogs raised under tick-free conditions were allocated to two
groups: 11 dogs were vaccinated with a commercial borrelia
vaccine and subsequently developed detectable antibody titers; 12
were walked in a tick-endemic area on two consecutive days. On
day five after exposure engorged ticks were removed from the 12
dogs and analyzed for Borrelia DNA in real-time PCR assay. Blood
samples were taken before exposure/vaccination and at defined
time points thereafter.

]]>
http://lymebook.com/fight/humoral-immune-response-in-dogs-with-borrelia/feed/ 0
XMRV and Chronic Fatigue Syndrome http://lymebook.com/fight/xmrv-and-chronic-fatigue-syndrome/ http://lymebook.com/fight/xmrv-and-chronic-fatigue-syndrome/#respond Tue, 13 Jul 2010 05:16:38 +0000 http://lymebook.com/fight/?p=1335 Excerpt:

June 17, 2010 — Concern that a new human gamma-retrovirus may be transmissible through blood has led one infectious diseases specialist to recommend new steps to protect the US blood supply against possible infection with the virus.

The transfusion medicine organization AABB has formed a task force to study the transmission potential of xenotropic murine leukemia virus–related virus (XMRV), which has been linked to familial prostate cancer and, more recently, to chronic fatigue syndrome (CFS).

]]>
http://lymebook.com/fight/xmrv-and-chronic-fatigue-syndrome/feed/ 0
Borreliosis & Depression in psoriasis – a case report http://lymebook.com/fight/borreliosis-depression-in-psoriasis-a-case-report/ http://lymebook.com/fight/borreliosis-depression-in-psoriasis-a-case-report/#respond Wed, 28 Apr 2010 05:16:46 +0000 http://lymebook.com/fight/?p=1022 Full article: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20369726&retmode=ref&cmd=prlinks

Excerpt:

Lyme disease is a multisystem infectious disease with a wide
variety of symptoms involving the skin as well as the nervous
system. Lyme disease is caused by spirochaete Borrelia
burgdorferi transmitted by Ixodes ticks in endemic regions.
A case of 45 year old woman suffering from borreliosis, psoriasis
and depression is presented in the paper. In the study a
standardized screening list was applied to evaluate the
psychiatric health state–Classification of Psychic Disorders
(DSM-IV) and Hamilton Scale. Patient was diagnosed with a major
depressive episode (MDE) according to DSM-IV Diagnosis Criteria.
Patient obtained a score 21 on the 24-item in Hamilton Rating
Scale of Depression.

]]>
http://lymebook.com/fight/borreliosis-depression-in-psoriasis-a-case-report/feed/ 0
Bartonellosis: an emerging infectious disease http://lymebook.com/fight/bartonellosis-an-emerging-infectious-disease/ http://lymebook.com/fight/bartonellosis-an-emerging-infectious-disease/#respond Sat, 10 Apr 2010 04:42:43 +0000 http://lymebook.com/fight/?p=972 Bartonellosis: an emerging infectious disease of
zoonotic importance to animals,and human beings.

J Vet Emerg Crit Care (San Antonio). 2010 Feb 1;20(1):8-30.

Bartonellosis: an emerging infectious disease of zoonotic
importance to animals and human beings.

Breitschwerdt EB, Maggi RG, Chomel BB, Lappin MR.

Department of Clinical Sciences, Center for Comparative Medicine
and Translational Research, College of Veterinary Medicine, North
Carolina State University, Raleigh, NC 27606.

Objective- To provide a review of clinically relevant
observations related to Bartonella species as emerging pathogens
in veterinary and human medicine. Data
Sources- Literature as cited in PubMed and as generated by each
of the authors who have contributed to various aspects of the
clinical understanding of bartonellosis. Human Data Synthesis-
Important historical and recent publications illustrating the
evolving role of animal reservoirs as a source of human
infection. Veterinary Data Synthesis- Comprehensive review of the
veterinary literature.

Conclusions- In addition to inducing life-threatening illnesses,
such as endocarditis, myocarditis, and meningoencephalitis and
contributing to chronic debilitating disease, such as arthritis,
osteomyelitis, and granulomatous inflammation in cats, dogs, and
potentially other animal species; pets and wildlife species can
serve as persistently infected reservoir hosts for the
transmission of Bartonella spp. infection to veterinary
professionals and others with direct animal contact.

http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pu
bmed&id=20230432&retmode=ref&cmd=prlinks
PMID: 20230432  [PubMed – in process]

]]>
http://lymebook.com/fight/bartonellosis-an-emerging-infectious-disease/feed/ 0
Treatment of Lyme borreliosis http://lymebook.com/fight/treatment-of-lyme-borreliosis/ http://lymebook.com/fight/treatment-of-lyme-borreliosis/#respond Mon, 01 Mar 2010 07:00:08 +0000 http://lymebook.com/fight/?p=889 Excerpt:

Borrelia burgdorferi sensu lato is the causative agent
of Lyme borreliosis in humans. This inflammatory disease can
affect the skin, the peripheral and central nervous system, the
musculoskeletal and cardiovascular system and rarely the eyes.
Early stages are directly associated with viable bacteria at the
site of inflammation. The pathogen-host interaction is complex
and has been elucidated only in part. B. burgdorferi is highly
susceptible to antibiotic treatment and the majority of patients
profit from this treatment

]]>
http://lymebook.com/fight/treatment-of-lyme-borreliosis/feed/ 0
Persistence mechanisms in tick-borne diseases http://lymebook.com/fight/persistence-mechanisms-in-tick-borne-diseases/ http://lymebook.com/fight/persistence-mechanisms-in-tick-borne-diseases/#respond Tue, 22 Dec 2009 07:10:40 +0000 http://lymebook.com/fight/?p=703 The use of new, highly sensitive diagnostic methods has revealed persistent
infections to be a common feature of different tick-borne diseases, such as
babesiosis, anaplasmosis and heartwater. Antigenic variation can contribute to
disease persistence through the continual elaboration of new surface structures,
and we know in several instances how this is achieved.

Known or suspected mechanisms of persistence in babesial parasites include cytoadhesion and rapid
variation of the adhesive ligand in Babesia bovis and genetic diversity in
several merozoite stage proteins of different Babesia spp. In Anaplasma,
extensive variation in the pfam01617 gene family accompanies cycling of organism
levels in chronic infection. One result from the pioneering research at
Onderstepoort is the definition of a related polymorphic gene family that is
likely involved in immunity against heartwater disease. We are beginning to
understand the sizes of the antigenic repertoires and full definition is close,
with the possibility of applying simultaneous high-throughput sequencing to the
order of 1000 small genomes. We also, for the first time, can consider modifying
these genomes and looking at effects on persistence and virulence. However,
important biological questions remain unanswered; for example, why we are seeing
a new emerging Anaplasma infection of humans and is infection of endothelial
cells by Anaplasma significant to persistence in vivo.

http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19967928&retmode=ref&cmd=prlinks
PMID: 19967928  [PubMed – in process]

Onderstepoort J Vet Res. 2009 Mar;76(1):53-8.

Persistence mechanisms in tick-borne diseases.

Barbet AF.

Department of Infectious Diseases & Pathology, College of Veterinary Medicine,
University of Florida, Gainesville, Florida, USA.

]]>
http://lymebook.com/fight/persistence-mechanisms-in-tick-borne-diseases/feed/ 0
Ineffectiveness of Tigecycline Against Persistent Borrelia burgdorferi http://lymebook.com/fight/ineffectiveness-of-tigecycline-against-persistent-borrelia-burgdorferi/ http://lymebook.com/fight/ineffectiveness-of-tigecycline-against-persistent-borrelia-burgdorferi/#respond Tue, 22 Dec 2009 06:59:31 +0000 http://lymebook.com/fight/?p=695 Center for Comparative Medicine, Schools of Medicine and Veterinary Medicine,
University of California at Davis, One Shields Avenue, Davis, California 95616;
Division of Infectious Diseases, Department of Medicine, State University of New
York at Stony Brook, Stony Brook, New York 11794.

The effectiveness of a new first in class antibiotic, tigecycline
(glycylcycline), was evaluated during the early dissemination (1 week), early
immune (3 weeks), or late persistent (4 months) phases of Borrelia burgdorferi
infection in C3H mice. Mice were treated with high or low doses of tigecycline,
saline (negative-effect controls), or a previously published regimen of
ceftriaxone (positive-effect controls). Infection status was assessed at 3
months after treatment by culture, quantitative ospA real-time PCR, and
subcutaneous transplantation of joint and heart tissue into SCID mice. Tissues
from all saline-treated mice were culture- and ospA PCR-positive; tissues from
all antibiotic-treated mice were culture-negative; and some of the tissues from
most of the mice treated with antibiotics were ospA PCR-positive, although the
DNA marker load was markedly decreased compared to saline-treated mice.
Antibiotic treatment during the early stage of infection appeared to be more
effective than treatment that began during later stages of infection. The
viability of non-cultivable spirochetes in antibiotic-treated mice (demonstrable
by PCR) was confirmed by transplantation of tissue allografts from treated mice
into SCID mice, with dissemination of spirochetal DNA to multiple recipient
tissues, and by xenodiagnosis, including acquisition by ticks, transmission by
ticks to SCID mice, and survival through molting into nymphs and then into
adults. Furthermore, PCR-positive heart base tissue from antibiotic-treated mice
revealed RNA transcription of several B. burgdorferi genes. Results extended
previous studies with ceftriaxone, indicating that antibiotic treatment is
unable to clear persisting spirochetes, which remain viable and infectious, but
are non- or slowly dividing.

http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19995919&retmode=ref&cmd=prlinks
PMID: 19995919  [PubMed – as supplied by publisher]

Antimicrob Agents Chemother. 2009 Dec 7; [Epub ahead of print]

Ineffectiveness of Tigecycline Against Persistent Borrelia burgdorferi.

Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ.

Center for Comparative Medicine, Schools of Medicine and Veterinary Medicine,
University of California at Davis, One Shields Avenue, Davis, California 95616;
Division of Infectious Diseases, Department of Medicine, State University of New
York at Stony Brook, Stony Brook, New York 11794.

]]>
http://lymebook.com/fight/ineffectiveness-of-tigecycline-against-persistent-borrelia-burgdorferi/feed/ 0
Antiviral Activities of Artemisinin, Artesunate http://lymebook.com/fight/antiviral-activities-of-artemisinin-artesunate/ http://lymebook.com/fight/antiviral-activities-of-artemisinin-artesunate/#respond Wed, 16 Dec 2009 17:29:05 +0000 http://lymebook.com/fight/?p=677 Traditional Chinese medicine commands a unique position among all traditional medicines because of its 5000 years of history. Our own interest in natural products from traditional Chinese medicine was triggered in the 1990s, by artemisinin‐type sesquiterpene lactones from Artemisia annua L. As demonstrated in recent years, this class of compounds has activity against malaria, cancer cells, and schistosomiasis. Interestingly, the bioactivity of artemisinin and its semisynthetic derivative artesunate is even broader and includes the inhibition of certain viruses, such as human cytomegalovirus and other members of the Herpesviridae family (e.g., herpes simplex virus type 1 and Epstein‐Barr virus), hepatitis B virus, hepatitis C virus, and bovine viral diarrhea virus. Analysis of the complete profile of the pharmacological activities and molecular modes of action of artemisinin and artesunate and their performance in clinical trials will further elucidate the full antimicrobial potential of these versatile pharmacological tools from nature.

 
Clinical Infectious Diseases 2008;47:804–811

1058-4838/2008/4706-0011$15.00
DOI: 10.1086/591195
REVIEW ARTICLE

The Antiviral Activities of Artemisinin and Artesunate

Thomas Efferth,1

Marta R. Romero,3,5

Dana G. Wolf,4

Thomas Stamminger,2

Jose J. G. Marin,5 and

Manfred Marschall2

1German Cancer Research Center, Pharmaceutical Biology, Im Neuenheimer Feld 280, Heidelberg, and 2Virological Institute of the University Hospital Erlangen, Clinical and Molecular Virology, University of Erlangen, Nuremberg, Germany; 3Medical Research Council Clinical Science Center, Hammersmith Campus, Imperial College, London, United Kingdom; 4Hadassah University Hospital, Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel; and 5University of Salamanca, Laboratory of Experimental Hepatology and Drug Targeting, CIOBERehd, Salamanca, Spain

Received 4 February 2008; accepted 10 May 2008; electronically published 12 August 2008.

Reprints or correspondence: Dr. Thomas Efferth, German Cancer Research Center, Pharmaceutical Biology (C015), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany ().
]]>
http://lymebook.com/fight/antiviral-activities-of-artemisinin-artesunate/feed/ 0